FDA OKs first-of-its-kind diabetes drug from J&J
WASHINGTON (AP) — The Food and Drug Administration on Friday approved a first-of-its-kind diabetes drug from Johnson & Johnson that uses a new method to lower blood sugar — flushing it out in patients’ urine.
